Dr. Mark D. Hurwitz
Claim this profileWestchester Medical Center
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
6 reported clinical trials
21 drugs studied
Area of expertise
1Prostate Cancer
Stage I
Stage II
2Prostate Adenocarcinoma
Affiliated Hospitals
Clinical Trials Mark D. Hurwitz is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
More about Mark D. Hurwitz
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mark D. Hurwitz has experience with
- Flutamide
- External Beam Radiation Therapy
- Apalutamide
- Bicalutamide
- Buserelin
- Degarelix
Breakdown of trials Mark D. Hurwitz has run
Prostate Cancer
Prostate Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark D. Hurwitz specialize in?
Mark D. Hurwitz focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage I patients, or patients who are Stage II.
Is Mark D. Hurwitz currently recruiting for clinical trials?
Yes, Mark D. Hurwitz is currently recruiting for 4 clinical trials in Valhalla New York. If you're interested in participating, you should apply.
Are there any treatments that Mark D. Hurwitz has studied deeply?
Yes, Mark D. Hurwitz has studied treatments such as Flutamide, External Beam Radiation Therapy, Apalutamide.
What is the best way to schedule an appointment with Mark D. Hurwitz?
Apply for one of the trials that Mark D. Hurwitz is conducting.
What is the office address of Mark D. Hurwitz?
The office of Mark D. Hurwitz is located at: Westchester Medical Center, Valhalla, New York 10595 United States. This is the address for their practice at the Westchester Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.